Abstract
Background Retroperitoneal sarcomas are rare malignant tumours with aggressive course of disease and high local recurrence rate. The evaluation and treatment of retroperitoneal sarcomas are challenging because the tumours are relatively rare and frequently present with advanced disease in an anatomically complex location. We analyzed the treatment and survival in 96 patients with primary or recurrent retroperitoneal sarcoma (RPS).
Highlights
BioMed CentralOpen Access from 24th Annual Meeting of the National Cancer Institute of Mexico Mexico City, Mexico
Retroperitoneal sarcomas are rare malignant tumours with aggressive course of disease and high local recurrence rate
The evaluation and treatment of retroperitoneal sarcomas are challenging because the tumours are relatively rare and frequently present with advanced disease in an anatomically complex location
Summary
Open Access from 24th Annual Meeting of the National Cancer Institute of Mexico Mexico City, Mexico. Published: 5 February 2007 BMC Cancer 2007, 7(Suppl 1):A45 doi:10.1186/1471-2407-7-S1-A45. islen2t4iilathbleohr>erAelso.s-lores Gallardo-Rincon, Luis A Herrera, Myrna Candelaria, Adolfo Fuentes-Alburo Meeting abstracts – A single PDF containing all
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
